Año: 2018
Journal Impact Factor (JIF): 4.2550
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PERIPHERAL VASCULAR DISEASE | SCIE | 12/65 | Q1 | T1 | D2 |
| CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | 37/136 | Q2 | T1 | D3 |
Año: 2018
Journal Citation Indicator (JCI): 1,090
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CARDIAC & CARDIOVASCULAR SYSTEMS | 42/191 | Q1 | T1 | D3 | 78,27 |
| PERIPHERAL VASCULAR DISEASE | 14/84 | Q1 | T1 | D2 | 83,93 |
Año:
2018
CiteScore:
7,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 37/324 | Q1 | T1 | D2 |
SJR año:
2018
Factor de Impacto:
1,748
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 42/384 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Amgen | - |
| MSD | - |
| Pfizer Independent Grant for Learning Change 2014 | 16157823 |
| Sanofi-Aventis | - |
| # | Autor |
|---|---|
| 1 | |
| 2 | |
| 3 | Stevens, CAT |
| 4 | Akram, A |
| 5 | Freiberger, T |
| 6 | Hovingh, GK |
| 7 | Kastelein, JJP |
| 8 | Mata, P |
| 9 | Raal, FJ |
| 10 | Santos, RD |
| 11 | Soran, H |
| 12 | Watts, GF |
| 13 | Abifadel, M |
| 14 | Aguilar-Salinas, CA |
| 15 | Al-Khnifsawi, M |
| 16 | AlKindi, FA |
| 17 | Alnouri, F |
| 18 | Alonso, R |
| 19 | Al-Rasadi, K |
| 20 | Al-Sarraf, A |
| 21 | Ashavaid, TF |
| 22 | Binder, CJ |
| 23 | Bogsrud, MP |
| 24 | Bourbon, M |
| 25 | Bruckert, E |
| 26 | Chlebus, K |
| 27 | Corral, P |
| 28 | Descamps, O |
| 29 | Durst, R |
| 30 | Ezhov, M |
| 31 | Fras, Z |
| 32 | Genest, J |
| 33 | Groselj, U |
| 34 | Harada-Shiba, M |
| 35 | Kayikcioglu, M |
| 36 | Lalic, K |
| 37 | Lam, CSP |
| 38 | Latkovskis, G |
| 39 | Laufs, U |
| 40 | Liberopoulos, E |
| 41 | Lin, J |
| 42 | Maher, V |
| 43 | Majano, N |
| 44 | Marais, AD |
| 45 | Marz, W |
| 46 | Mirrakhimov, E |
| 47 | Miserez, AR |
| 48 | Mitchenko, O |
| 49 | Nawawi, HM |
| 50 | Nordestgaard, BG |
| 51 | Paragh, G |
| 52 | Petrulioniene, Z |
| 53 | Pojskic, B |
| 54 | Postadzhiyan, A |
| 55 | Reda, A |
| 56 | Reiner, Z |
| 57 | Sadoh, WE |
| 58 | Sahebkar, A |
| 59 | Shehab, A |
| 60 | Shek, AB |
| 61 | Stoll, M |
| 62 | Su, TC |
| 63 | Subramaniam, T |
| 64 | Susekov, AV |
| 65 | Symeonides, P |
| 66 | Tilney, M |
| 67 | Tomlinson, B |
| 68 | Truong, TH |
| 69 | Tselepis, AD |
| 70 | Tybjaerg-Hansenb, A |
| 71 | Vazquez-Cardenas, A |
| 72 | Viigimaa, M |
| 73 | Vohnout, B |
| 74 | Widen, E |
| 75 | Yamashita, S |
| 76 | Banach, M |
| 77 | Gaita, D |
| 78 | Jiang, LX |
| 79 | Nilsson, L |
| 80 | Santos, LE |
| 81 | Schunkert, H |
| 82 | Tokgozoglu, L |
| 83 | Car, J |
| 84 | Catapano, AL |
| 85 | Ray, KK |
| # | Autoría grupal |
| 86 | EAS Familial Hypercholestero |
| 87 | EAS Familial Hypercholesterolaemia |
